|
70
|
227
|
4o83A |
Saicar synthetase (type-1) in complex with adp/amp |
|
78
|
274
|
4n6yA |
Pim1 complexed with a phenylcarboxamide |
|
85
|
263
|
4nwmA |
Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with bms-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide |
|
72
|
263
|
4nl0A |
Structural and functional characterization of a novel alpha kinase in complex with adp from entamoeba histolytica |
|
71
|
310
|
4o38A |
Crystal structure of the human cyclin g associated kinase (gak) |
|
72
|
266
|
4o0sA |
Crystal structures of human kinase aurora a |
|
88
|
263
|
4otfA |
Crystal structure of the kinase domain of bruton's tyrosine kinase with gdc0834 |
|
72
|
266
|
4o0uA |
Crystal structures of human kinase aurora a |
|
75
|
232
|
4o7lA |
Saicar synthetase (type-2) in complex with adp |
|
93
|
296
|
4n57A |
Crystal structure of aminoglycoside phosphotransferase aph(2'')-iva adp complex |
|
71
|
235
|
4nyeA |
Structures of saicar synthetase (purc) from streptococcus pneumoniae with adp, mg2+, air and l-asp |
|
84
|
296
|
4obqA |
Map4k4 in complex with inhibitor (compound 31), n-[3-(4-aminoquinazolin-6-yl)-5-fluorophenyl]-2-(pyrrolidin-1-yl)acetamide |
|
87
|
302
|
4nkaA |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2 |
|
71
|
227
|
4o84A |
Saicar synthetase (type-1) in complex with gmp |
|
102
|
359
|
4nm0A |
Crystal structure of peptide inhibitor-free gsk-3/axin complex |
|
71
|
224
|
4o7sA |
Saicar synthetase (type-2) in complex with tmp/tdp |
|
96
|
291
|
4o0yA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
87
|
335
|
4othA |
Crystal structure of prk1 catalytic domain in complex with ro-31-8220 |
|
70
|
281
|
4o27B |
Crystal structure of mst3-mo25 complex with wif motif |
|
88
|
324
|
4or5A |
Crystal structure of hiv-1 tat complexed with human p-tefb and aff4 |
|
88
|
291
|
4o0vA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
106
|
352
|
4n0sA |
Complex of erk2 with caffeic acid |
|
96
|
309
|
4nw5A |
Rsk2 n-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 8 |
|
107
|
379
|
4nm3A |
Crystal structure of gsk-3/axin complex bound to phosphorylated n-terminal auto-inhibitory ps9 peptide |
|
88
|
291
|
4njdA |
Structure of p21-activated kinase 4 with a novel inhibitor ky-04031 |
|
94
|
291
|
4o0xA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
88
|
336
|
4otgA |
Crystal structure of prk1 catalytic domain in complex with lestaurtinib |
|
97
|
365
|
4o2zA |
Crystal structure of mpk3 from leishmania donovani, ldbpk_100540 in the presence of nvp-bbt594 |
|
94
|
263
|
4otrA |
Crystal structure of btk kinase domain complexed with 6-cyclopropyl-2-[3-[5-[[5-(4-ethylpiperazin-1-yl)-2-pyridyl]amino]-1-methyl-6-oxo-3-pyridyl]-2-(hydroxymethyl)phenyl]-8-fluoro-isoquinolin-1-one |
|
92
|
293
|
4nfmA |
Human tau tubulin kinase 1 (ttbk1) |
|
73
|
227
|
4o81A |
Saicar synthetase (type-1) in complex with adp and amp |
|
103
|
349
|
4n4sA |
A double mutant rat erk2 in complex with a pyrazolo[3,4-d]pyrimidine inhibitor |
|
97
|
309
|
4nw6A |
Rsk2 n-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27 |
|
87
|
298
|
4obpA |
Map4k4 in complex with inhibitor (compound 29), 6-(2-fluoropyridin-4-yl)pyrido[3,2-d]pyrimidin-4-amine |
|
106
|
378
|
4nu1A |
Crystal structure of a transition state mimic of the gsk-3/axin complex bound to phosphorylated n-terminal auto-inhibitory ps9 peptide |
|
81
|
295
|
4oboA |
Map4k4 in complex with inhibitor (compound 22), 6-(3-chlorophenyl)quinazolin-4-amine |
|
104
|
360
|
4nm7A |
Crystal structure of gsk-3/axin complex bound to phosphorylated wnt receptor lrp6 e-motif |
|
105
|
345
|
4o6eA |
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of erk2 |
|
91
|
265
|
4ot6A |
Crystal structure of btk kinase domain complexed with 4-methanesulfonyl-n-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide |
|
74
|
267
|
4o0wA |
Crystal structures of human kinase aurora a |
|
93
|
263
|
4ot5A |
Crystal structure of btk kinase domain complexed with 4-tert-butyl-n-(3-{8-[4-(4-methyl-piperazine-1-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide |
|
84
|
323
|
4ogrA |
Crystal structure of p-tefb complex with aff4 and tat |
|
79
|
341
|
4nttA |
Structure of the catalytic subunit of camp-dependent protein kinase bound to adp and one magnesium ion |
|
87
|
277
|
4o2pA |
Kinase domain of csrc in complex with a substituted pyrazolopyrimidine |
|
87
|
307
|
4nusA |
Rsk2 n-terminal kinase in complex with ljh685 |
|
73
|
227
|
4o82A |
Saicar synthetase (type-1) in complex with adp and amp in both chains |
|
113
|
352
|
4nifB |
Heterodimeric structure of erk2 and rsk1 |
|
90
|
263
|
4otqA |
Crystal structure of btk kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea |
|
111
|
329
|
4oucA |
Structure of human haspin in complex with histone h3 substrate |
|
88
|
335
|
4otiA |
Crystal structure of prk1 catalytic domain in complex with tofacitinib |
